The maker of Viagra, Lipitor and Advil has been slashing thousands of jobs since acquiring rival Wyeth in 2009.
Now, as several of its key products run out of patent protection, it is also downsizing its research and development spending.
The company plans to still cut another 5,530 employees -- or 5% of its global workforce. While many of those jobs cuts will come from the closure of a factory in Sandwich, England, they will also affect many U.S. employees who work in R&D roles.
These young job seekers graduated into the worst labor market since the Great Depression.
|Trump & Boeing: It's not about Air Force One, it's about China|
|Ex-CIA boss amazed Trump doesn't believe Russia hacked US election|
|India's cash crisis is 'a mammoth tragedy,' says former prime minister|
|JCPenney, Kohl's, Macy's and Sears sued over misleading prices|
|'DuckTales' teaser will quack you up|